Skip to main content
Log in

Urinary Tract Infections in Patients with Spinal Cord Lesions

Treatment and Prevention

  • Therapy in Practice
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Even though the mortality due to urinary tract complications has decreased dramatically during the last decades in individuals with spinal cord lesions (SCL), urinary tract infections (UTI) still cause significant morbidity in this population.

Complicated UTI are caused by a much wider variety of organisms in individuals with SCL than in the general population and are often polymicrobial. Escherichia coli, Pseudomonas spp., Klebsiella spp., Proteus spp., Serratia spp., Providencia spp., enterococci, and staphylococci are the most frequently isolated bacteria in urine specimens taken from individuals with SCL. There is no doubt that the greatest risk for complicated UTI in these individuals is the use of an indwelling catheter. Intermittent catheterisation during the rehabilitation phase has been shown to lower the rate of UTI, and virtually eliminate many of the complications associated with indwelling catheters.

Persons with SCL should only be treated for bacteriuria if they have symptoms. Generally, it is advisable to use antibacterial agents with little or no impact on the normal flora. Single agent therapy — in accordance with antimicrobial susceptibility test — is preferred. We advise extending treatment to at least 5 days, and in those with reinfection or relapsing UTI, at least 7 to 14 days, depending on the severity of the infection.

The diagnosis of structural and/or functional risk factors is essential in order to plan an optimal treatment for UTI in individuals with SCL, which should include treatment of simultaneously occurring predisposing factors. The treatment of structural risk factors follows general urological principles, aiming for sufficient outlet from the bladder with minimal residual urine and low pressure voiding.

For prevention of UTI, general cleanliness and local hygiene should be encouraged. If the patient has a reinfection or relapsing symptomatic UTI, it is important to check for inadequately treated infection and complications, which need special attention, in particular residual urine and urinary stones. No reliable evidence exists of the effectiveness of cranberry juice and other cranberry products. Prophylactic antibacterials should only be used in patients with recurrent UTI where no underlying cause can be found and managed, and in particular if the upper urinary tract is dilated. Antibacterials should not be used for the prevention of UTI in individuals with SCL and indwelling catheters. However, the use of prophylactic antibacterials for individuals with SCL using intermittent catheterisation or other methods of bladder emptying is controversial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

References

  1. DeVivo MJ, Kartus PL, Stover SL, et al. Cause of death for patients with spinal cord injuries. Arch Intern Med 1989; 149: 1761–6

    Article  PubMed  CAS  Google Scholar 

  2. Ducker TB. Treatment of spinal cord injury. N Engl J Med 1990; 322: 1459–61

    Article  PubMed  CAS  Google Scholar 

  3. Hartkopp A, Brønnum-Hansen H, Seidenschnur A-M, et al. Survival and cause of death after traumatic spinal cord injury. A long-term epidemiological survey from Denmark [Corrigendum Spinal Cord 1997; 35: 862–4]. Spinal Cord 1997; 35: 76–85

    Article  PubMed  CAS  Google Scholar 

  4. Hackler RH. A 25-year prospective mortality study in the spinal cord injury patient: comparison with long-term living paraplegics. J Urol 1977; 117: 486–8

    PubMed  CAS  Google Scholar 

  5. Selzman AA, Hampel N. Urologic complications of spinal cord injury. Urol Clin North Am 1993; 20: 453–64

    PubMed  CAS  Google Scholar 

  6. Biering-Sørensen F, Nielans H-M, Dørflinger T, et al. Urological situation five years after spinal cord injury. Scand J Urol Nephrol 1999; 33: 157–61

    Article  PubMed  Google Scholar 

  7. Cardenas DD, Hooton TM. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil 1995; 76: 272–80

    Article  PubMed  CAS  Google Scholar 

  8. Elden H, Hizmetli S, Nacitarhan V, et al. Relapsing significant bacteriuria: effect on urinary tract infection in patients with spinal cord injury. Arch Phys Med Rehabil 1997; 78: 468–70

    Article  PubMed  CAS  Google Scholar 

  9. Galloway A. Prevention of urinary tract infection in patients with spinal cord injury — a microbiological review. Spinal Cord 1997; 35: 198–204

    Article  PubMed  CAS  Google Scholar 

  10. Waites KB, Canupp KC, DeVivo MJ. Epidemiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehabil 1993; 74: 691–5

    Article  PubMed  CAS  Google Scholar 

  11. Maynard FM, Diokno AC. Urinary infection and complications during clean intermittent catheterisation following spinal cord injury. J Urol 1984; 132: 943–6

    PubMed  CAS  Google Scholar 

  12. Whiteneck GG, Charlifue SW, Frankel HL, et al. Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago. Paraplegia 1992; 30: 617–30

    Article  PubMed  CAS  Google Scholar 

  13. Hull R, Rudy D, Donovan W, et al. Urinary tract infection pro-phylaxis using escherichia coli 83972 in spinal cord injured patients. J Urol 2000; 163: 872–7

    Article  PubMed  CAS  Google Scholar 

  14. Faarvang KL, Müller P, Lomberg B, et al. Screening for bacteriuria in patients with spinal cord lesion: dipstick test, microscopic examination and urine culture. Spinal Cord 2000; 39: 106–8

    Article  Google Scholar 

  15. Gribble MJ, McCallum NM, Schechter MT. Evaluation of diagnostic criteria for bacteriuria in acutely spinal cord injured patients undergoing intermittent catheterization. Diagn Microbiol Infect Dis 1988; 9: 197–206

    Article  PubMed  CAS  Google Scholar 

  16. Stover SL, Lloyd K, Waites KB, et al. Urinary tract infection in spinal cord injury. Arch Phys Med Rehabil 1989; 70: 47–54

    PubMed  CAS  Google Scholar 

  17. Biering-Sørensen F, Hoiby N, Nordenbo A, et al. Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomised, cross-over, placebo controlled study in patients with spinal cord lesion [Erratum appears in J Urol 1994; 151: 1032]. JUrol 1994; 151: 105–8

    Google Scholar 

  18. Sotolongo JR, Koleilat N. Significance of asymptomatic bacteriuria in spinal cord injury patients on condom catheter. J Urol 1990; 143: 979–80

    PubMed  Google Scholar 

  19. Moser C, Kriegbaum NJ, Larsen SO, et al. Antibodies to urinary tract pathogens in patients with spinal cord lesions. Spinal Cord 1998; 36: 613–6

    Article  PubMed  CAS  Google Scholar 

  20. Waites KB, Chen Y, DeVivo MJ, et al. Antimicrobial resistance in gram-negative bacteria isolated from the urinary tract in community-residing persons with spinal cord injury. Arch Phys Med Rehabil 2000; 81: 764–9

    PubMed  CAS  Google Scholar 

  21. Larsen LD, Chamberlin DA, Khonsari F, et al. Retrospective analysis of urologic complications in male patients with spinal cord injury managed with and without indwelling urinary catheters. Urology 1997; 50: 418–22

    Article  PubMed  CAS  Google Scholar 

  22. Cardenas DD, Mayo ME. Bacteriuria with fever after spinal cord injury. Arch Phys Med Rehabil 1987; 68: 291–3

    PubMed  CAS  Google Scholar 

  23. Prieto-Fingerhut T, Banovac K, Lynne CM. A study comparing sterile and nonsterile urethral catheterization in patients with spinal cord injury. Rehabilitation Nursing 1997; 22: 299–302

    Article  PubMed  CAS  Google Scholar 

  24. Bennett CJ, Young MN, Razi SS, et al. The effect of urethral introducer tip catheters on the incidence of urinary tract infection outcomes in spinal cord injured patients. J Urol 1997; 158:519–21

    Article  PubMed  CAS  Google Scholar 

  25. Vaidyanathan S, Soni BM, Dundas S, et al. Urethral cytology in spinal cord injury patients performing intermittent catheterization. Paraplegia 1994; 32: 493–500

    Article  PubMed  CAS  Google Scholar 

  26. Biering-Sørensen F, Nielsen K, Hansen HV. Urethral epithelial cells on the surface on hydrophilic catheters after intermittent catheterization: cross-over study with two catheters. Spinal Cord 1999; 37: 299–300

    Article  PubMed  Google Scholar 

  27. Waller L, Jonsson O, Norlén L, et al. Clean intermittent catheterization in spinal cord injury patients: long-term followup of a hydrophilic low friction technique. J Urol 1995; 153: 345–8

    Article  PubMed  CAS  Google Scholar 

  28. Gallien P, Nicolas B, Robineau S, et al. Influence of urinary management on urologic complications in a cohort of spinal cord injury patients. Arch Phys Med Rehabil 1998; 79: 1206–9

    Article  PubMed  CAS  Google Scholar 

  29. Semeniuk H, Church D. Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections. J Clin Microbiol 1999; 37: 3051–2

    PubMed  CAS  Google Scholar 

  30. Schlager TA, Dilks S, Trudell J, et al. Bacteriuria in children with neurogenic bladder treated with intermittent catheterization: natural history. J Pediatr 1995; 126: 490–6

    Article  PubMed  CAS  Google Scholar 

  31. Waites KB, Canupp KC, DeVivo MJ. Eradication of urinary tract infection following spinal cord injury. Paraplegia 1993; 31: 645–52

    Article  PubMed  CAS  Google Scholar 

  32. Høiby N. Ecological antibiotic policy. J Antimicrob Chemother 2000; 46 Suppl. S1: 59–62

    Article  Google Scholar 

  33. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29:745–58

    Article  PubMed  CAS  Google Scholar 

  34. Beaucaire G. Does once-daily dosing prevent nephrotoxicity in all aminoglycosides equally? Clin Microbiol Infect 2000; 6: 357–62

    Article  PubMed  CAS  Google Scholar 

  35. Jepson RG, Mihaljevic L, Craig J. Cranberries for treating urinary tract infections. Cochrane Database of Systematic Reviews. Issue 2, 2000

  36. Harkins KJ. What’s the use of cranberry juice? Age Ageing 2000; 29: 9–12

    Article  PubMed  CAS  Google Scholar 

  37. Bernardo NO, Smith AD: Chemolysis of urinary calculi. Urol Clin N Am 2000; 27: 355–66

    Article  CAS  Google Scholar 

  38. Paik ML, Resnick MI. Is there a role for open stone surgery? Urol Clin N Am 2000; 27: 323–32

    Article  CAS  Google Scholar 

  39. Caine M. The prsent role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia. J Urol 1986; 136: 1–4

    PubMed  CAS  Google Scholar 

  40. Wein AJ. Neuromuscular dysfunction of lower urinary tract. In: Walsh PC, Retik AB, Darracott Vaughan Jr E, et al., editors. Campbell’s urology. Philadelphia: Saunders, 1998: 953–1006

    Google Scholar 

  41. Al-Ali AM, Salman G, Rasheed A, et al. Phenoxybenzamin in the management of neuropathic bladder following spinal cord injury. Aust N Z J Surg 1999; 69: 660–3

    Article  PubMed  CAS  Google Scholar 

  42. Perkash I. Efficacy and safety of terazosin to improve voiding in spinal cord injury patients. J Spinal Cord Med 1995; 18: 236–9

    PubMed  CAS  Google Scholar 

  43. Swierzewski SJ, Gormley EA, Belville WD, et al. The effect of terazosin on bladder function in the spinal cord injured patient. J Urol 1994; 151:951–4

    PubMed  Google Scholar 

  44. Thind P, Lose G, Colstrup H, et al. The effect of alpha adrenoceptor stimulation and blockade on the static urethral sphincter function in healthy women. Scand J Urol Nephrol 1992; 26: 219–25

    Article  PubMed  CAS  Google Scholar 

  45. Catz A, Luttwak ZP, Agranov E, et al. The role of external sphincterotomy for patients with a spinal cord lesion. Spinal Cord 1997; 35: 48–51

    Article  PubMed  CAS  Google Scholar 

  46. Kim YH, Kattan MW, Boone TB. Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detrusor-sphincter dyssynergia. J Urol 1998; 159: 493–5

    Article  PubMed  CAS  Google Scholar 

  47. Juma S, Mostafavi M, Joseph A. Sphincterotomy: long term complications and warning signs. Neurourol Urodyn 1995; 14: 33–41

    Article  PubMed  CAS  Google Scholar 

  48. Yang CC, Mayo ME. External urethral sphincterotomy: long term follow-up. Neurourol Urodyn 1995; 14: 25–31

    Article  PubMed  CAS  Google Scholar 

  49. Wein AJ. The role of external sphincterotomy for patients with spinal cord lesion. J Urol 1998; 160: 961

    PubMed  CAS  Google Scholar 

  50. Chancellor MB, Gajewski J, Ackman CF, et al. Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. J Urol 1999; 161: 1545–50

    Article  PubMed  CAS  Google Scholar 

  51. Chancellor MB, Bennett C, Simineau AR, et al. Sphincteric stent versus external sphincterotomy in spinal cord injured men: prospective randomized multicenter trial. J Urol 1999b; 161: 1893–8

    Article  CAS  Google Scholar 

  52. Chartier-Kastler EJ, Thomas L, Bussel B, et al. A urethral stent for the treatment of detrusor-sphincter dyssynergia. Br J Urol 2000; 86: 52–7

    CAS  Google Scholar 

  53. Brindley GS. The first 500 patients with sacral anterior root stimulator implants: general description. Paraplegia 1994; 32: 795–805

    Article  PubMed  CAS  Google Scholar 

  54. McDougal WS. Use of intestinal segments and urinary diversion. In: Walsh PC, Retik AB, Darracott Vaughan Jr E, et al., editors. Campbell’s urology. Philadelphia: Saunders, 1998: 3121–61

    Google Scholar 

  55. Kevorkian CG, Merritt JL, Ilstrup DM. Methenamine mandelate with acidification: an effective urinary antiseptic in patients with neurogennic bladder. Mayo Clinic Proc 1984; 59: 523–9

    Article  CAS  Google Scholar 

  56. Krebs M, Halvorsen RB, Fishman U, et al. Prevention of urinary tract infection during intermittent catheterization. J Urol 1985; 131: 82–5

    Google Scholar 

  57. Castelló T, Girona L, Gomez MR, et al. The possible value of ascorbic acid as a prophylactic agent for urinary tract infection. Spinal Cord 1996; 34: 592–3

    Article  PubMed  Google Scholar 

  58. Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. Issue 2, 2000

  59. Darouiche RO, Smith MS, Markowski J. Antibiotic prophylaxis for urodynamic testing in patients with spinal cord injury: a preliminary study. J Hosp Infect 1994; 28: 57–61

    Article  PubMed  CAS  Google Scholar 

  60. Kuhlemeier KV, Stover SL, Lloyd LK. Prophylactic antibacterial therapy for preventing urinary tract infections in spinal cord injury patients. J Urol 1985; 134: 514–6

    PubMed  CAS  Google Scholar 

  61. Mohler JL, Cowen DL, Flanigan RC. Suppresion and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. J Urol 1987; 138: 336–40

    PubMed  CAS  Google Scholar 

  62. Sandock DS, Gothe BG, Bodner DR. Trimethoprim-sulfamethoxazole prophylaxis against urinary tract infection in the chronic spinal cord injury patient. Paraplegia 1995; 33: 156–60

    Article  PubMed  CAS  Google Scholar 

  63. Anderson RU. Prophylaxis of bacteriuria during intermittent catheterization of the acute neurogenic bladder. J Urol 1980; 123: 364–6

    PubMed  CAS  Google Scholar 

  64. Duffy L, Smith AD. Nitrofurantoin macrocrystals prevent bacteriuria in intermittent self-catheterization. Urology 1982; 20: 47–9

    Article  PubMed  CAS  Google Scholar 

  65. Gribble MJ, Puterman M. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med 1993; 95: 141–52

    Article  PubMed  CAS  Google Scholar 

  66. Montgomerie JZ, Gilmore DS, Canawati HN, et al. Ceftazidine in treatment of urinary tract infection in patients with spinal cord injury: comparison with moxalactam. Urology 1990; 35: 93–5

    Article  PubMed  CAS  Google Scholar 

  67. Waites KB, Canupp KC, DeVivo MJ. Efficacy and tolerance of norfloxacin in treatment of complicated urinary tract infection in outpatients with neurogenic bladder secondary to spinal cord injury. Urology 1991; 38: 589–96

    Article  PubMed  CAS  Google Scholar 

  68. McLean JC, Nickel JC, Olson ME. Biofilm associated urinary tract infections. In: Lappin-Scott HM, Costerton JW. Microbial biofilms. Chapter 16. Cambridge University Press 1995: 261–73

  69. Saint S, Elmore JG, Sullivan SD, et al. The efficacy of silver alloy-coated urinary catheters in preventing urinary infection: a meta-analysis. Am J Med 1998; 105: 236–41

    Article  PubMed  CAS  Google Scholar 

  70. Darouiche RO, Hull RA. Bacterial interference for prevention of urinary tract infection: an overview. J Spinal Cord Med 2000; 23: 136–40

    PubMed  CAS  Google Scholar 

  71. Wullt B, Connell H, Röllano P, et al. Urodynamic factors influence the duration of Escherichia Coli bacteriuria in deliberately colonized cases. J Urol 1998; 159: 2057–62

    Article  PubMed  CAS  Google Scholar 

  72. Reid G. Probiotic therapy and functional foods for prevention of urinary tract infections: state of the art and science. Curr Infect Dis Rep 2000; 2: 518–22

    Article  PubMed  Google Scholar 

  73. Langermann S, Mollby R, Burlein JE, et al. Vaccination eith FimH adhesion protects cynomolus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 2000; 181:774–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fin Biering-Sørensen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biering-Sørensen, F., Bagi, P. & Høiby, N. Urinary Tract Infections in Patients with Spinal Cord Lesions. Drugs 61, 1275–1287 (2001). https://doi.org/10.2165/00003495-200161090-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200161090-00004

Keywords

Navigation